home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

SARS Attacking the Ribosome

 
  November, 2 2009 9:29
your information resource in human molecular genetics
 
     
A double attack by the SARS virus on host cell protein synthesis is shown in a study published online in Nature Structural & Molecular Biology. An understanding of such host targeting mechanisms may ultimately lead to therapeutic approaches to treat SARS.

Translation is the decoding of messenger RNAs to yield a protein, carried out by the ribosome. Many viruses interfere with the host cell's normal translation system, often requisitioning the host's own machinery for viral protein production. The SARS coronavirus protein nsp1 is known to be able to utilize such mechanisms to suppress production of host cell proteins.

Shinji Makino and colleagues now show that nsp1 modifies both host messages intended for translation and also the ribosome itself. This indicates that SARS uses a two-pronged approach to attack host translation.

Author contact:

Shinji Makino (University of Texas Medical Branch at Galveston, TX, USA)
E-mail: shmakino@utmb.edu

Abstract available online.

(C) Nature Structural & Molecular Biology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.